Phreesia, Inc. (PHR)
- Previous Close
20.46 - Open
20.56 - Bid 20.55 x 800
- Ask 20.56 x 1100
- Day's Range
20.36 - 21.02 - 52 Week Range
12.05 - 34.98 - Volume
489,464 - Avg. Volume
498,962 - Market Cap (intraday)
1.162B - Beta (5Y Monthly) 0.92
- PE Ratio (TTM)
-- - EPS (TTM)
-2.51 - Earnings Date May 29, 2024 - Jun 3, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
30.13
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
www.phreesia.com1,438
Full Time Employees
January 31
Fiscal Year Ends
Sector
Industry
Recent News: PHR
Performance Overview: PHR
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PHR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PHR
Valuation Measures
Market Cap
1.15B
Enterprise Value
1.08B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.13
Price/Book (mrq)
4.59
Enterprise Value/Revenue
3.03
Enterprise Value/EBITDA
-10.37
Financial Highlights
Profitability and Income Statement
Profit Margin
-38.42%
Return on Assets (ttm)
-22.25%
Return on Equity (ttm)
-50.77%
Revenue (ttm)
356.3M
Net Income Avi to Common (ttm)
-136.88M
Diluted EPS (ttm)
-2.51
Balance Sheet and Cash Flow
Total Cash (mrq)
439.85M
Total Debt/Equity (mrq)
2.60%
Levered Free Cash Flow (ttm)
2.28M